Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: Redefining FOLFIORINOX in Older Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial updating the use of the FOLFIRINOX regimen in older patients with metastatic pancreatic cancer. The study is active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)
  • Irinotecan (Irinotecan)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING